AU474797B2 - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
AU474797B2
AU474797B2 AU65592/74A AU6559274A AU474797B2 AU 474797 B2 AU474797 B2 AU 474797B2 AU 65592/74 A AU65592/74 A AU 65592/74A AU 6559274 A AU6559274 A AU 6559274A AU 474797 B2 AU474797 B2 AU 474797B2
Authority
AU
Australia
Prior art keywords
oxo
compound
dihydro
tetrazol
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU65592/74A
Other languages
English (en)
Other versions
AU6559274A (en
Inventor
DAVID MARTIN WATERS and MERVYN EVAN PEEL HEULWEN MOIRA RIDGWAY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allen and Hanburys Ltd
Original Assignee
Allen and Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen and Hanburys Ltd filed Critical Allen and Hanburys Ltd
Publication of AU6559274A publication Critical patent/AU6559274A/en
Application granted granted Critical
Publication of AU474797B2 publication Critical patent/AU474797B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU65592/74A 1973-02-26 1974-02-14 Heterocyclic compounds Expired AU474797B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9249/73 1973-02-26
GB924973A GB1433774A (en) 1973-02-26 1973-02-26 Heterocyclic compounds apparatus for conveying articles

Publications (2)

Publication Number Publication Date
AU6559274A AU6559274A (en) 1975-08-14
AU474797B2 true AU474797B2 (en) 1976-08-05

Family

ID=9868317

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65592/74A Expired AU474797B2 (en) 1973-02-26 1974-02-14 Heterocyclic compounds

Country Status (14)

Country Link
JP (1) JPS5029574A (enExample)
AT (1) AT329562B (enExample)
AU (1) AU474797B2 (enExample)
BE (1) BE811246A (enExample)
CA (1) CA1025856A (enExample)
CH (1) CH602707A5 (enExample)
DE (1) DE2407744A1 (enExample)
FR (1) FR2218896B1 (enExample)
GB (1) GB1433774A (enExample)
IE (1) IE38886B1 (enExample)
LU (1) LU69479A1 (enExample)
NL (1) NL7402613A (enExample)
SE (1) SE7401984L (enExample)
ZA (1) ZA74883B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2324304A2 (fr) * 1975-09-22 1977-04-15 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
US4186201A (en) 1977-02-07 1980-01-29 Riker Laboratories, Inc. Methods of using 8(tetrazol-5-ylcarbamoyl)isoquinoline compounds
US4264604A (en) 1977-07-01 1981-04-28 Ciba-Geigy Corporation Quinolonecarboxylic acid derivatives as bactericides
US4390541A (en) 1980-12-19 1983-06-28 Lilly Industries Limited Quinolone derivatives and their use in a method of controlling an immediate hypersensitivity disease
FR2509728A1 (fr) * 1981-07-17 1983-01-21 Roussel Uclaf Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
US4377579A (en) 1981-12-03 1983-03-22 Minnesota Mining And Manufacturing Company N-(Tetrazol-5-yl)phenazine-1-carboxamides
FR2537140B1 (fr) * 1982-12-07 1986-07-18 Roussel Uclaf Nouveaux derives de la 4-hydroxy-3-quinoleine carboxamide, leur sels, procede de preparation, application a titre de medicaments, et compositions les renfermant
KR960004827B1 (ko) * 1987-01-20 1996-04-16 다이닛뽄 세이야꾸 가부시끼가이샤 헤테로아릴카르복시아미드 유도체, 그의 제조방법 및 그것을 함유하는 의약조성물
US4959363A (en) * 1989-06-23 1990-09-25 Sterling Drug Inc. Quinolonecarboxamide compounds, their preparation and use as antivirals.
US6034100A (en) * 1993-03-10 2000-03-07 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting cytokine secretion
HUP0003258A3 (en) * 1997-08-25 2001-05-28 Neurogen Corp Branford Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands
US6143760A (en) * 1997-08-25 2000-11-07 Neurogen Corporation Substituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligands
AU2794099A (en) 1998-02-26 1999-09-15 Neurogen Corporation Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
EP1503759B1 (en) * 2002-05-14 2008-12-17 The Regents Of The University Of California Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
WO2005009971A1 (ja) 2003-07-24 2005-02-03 Astellas Pharma Inc. キノロン誘導体又はその塩
CA2881078C (en) * 2004-06-24 2018-10-02 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters
RU2525115C2 (ru) * 2004-06-24 2014-08-10 Вертекс Фармасьютикалз Инкорпорейтед Способ модуляции транспортеров атф-связывающей кассеты
EP2502912A3 (en) * 2004-06-24 2013-11-06 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
LT1993360T (lt) 2005-12-28 2017-06-12 Vertex Pharmaceuticals Incorporated N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
SI3330255T1 (sl) 2009-03-20 2021-03-31 Vertex Pharmaceuticals Incorporated Postopek izdelave regulatorja transmembranske prevodnosti pri cistični fibrozi
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
EP2819670B1 (en) 2012-02-27 2026-05-20 Vertex Pharmaceuticals Incorporated Pharmaceutical Composition and Their Administration
US9403802B2 (en) 2012-03-02 2016-08-02 Takeda Pharmaceutical Company Limited Heterocyclic compound and use therefor
WO2014077401A1 (ja) 2012-11-19 2014-05-22 武田薬品工業株式会社 含窒素複素環化合物
CA2963945C (en) 2014-10-07 2023-01-10 Vertex Pharmaceuticals Incorporated Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
CN105330602B (zh) * 2015-12-07 2018-02-09 江南大学 一种癸氧喹酯类似物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1383088A (en) * 1972-07-03 1975-02-05 Allen & Hanburys Ltd Pharmacologically active quinaldamide derivatives

Also Published As

Publication number Publication date
NL7402613A (enExample) 1974-08-28
FR2218896A1 (enExample) 1974-09-20
ATA149974A (de) 1975-08-15
JPS5029574A (enExample) 1975-03-25
ZA74883B (en) 1974-12-24
FR2218896B1 (enExample) 1977-09-09
DE2407744A1 (de) 1974-08-29
LU69479A1 (enExample) 1975-05-21
CA1025856A (en) 1978-02-07
IE38886B1 (en) 1978-06-21
IE38886L (en) 1974-08-26
AT329562B (de) 1976-05-25
CH602707A5 (enExample) 1978-07-31
GB1433774A (en) 1976-04-28
AU6559274A (en) 1975-08-14
BE811246A (fr) 1974-08-19
SE7401984L (enExample) 1974-08-27

Similar Documents

Publication Publication Date Title
AU474078B2 (en) Heterocyclic compounds
AU477220B2 (en) Heterocyclic amino compounds
AU468242B2 (en) 2-cyclohexene-1-one derivatives
AU6559274A (en) Heterocyclic compounds
AU472475B2 (en) Polene compounds
CA984843A (en) Heterocyclic compounds
AU6720074A (en) Heterocyclic compounds
AU474798B2 (en) Heterocyclic compounds
CA1027555A (en) Cephalosporin compounds
AU472474B2 (en) Heterocyclic anilids
ZA747526B (en) Heterocyclic compounds
CA1030539A (en) 4-hydroxy-3-nitrocarbostyril compounds
ZA747286B (en) Heterocyclic compounds
ZA738566B (en) Heterocyclic compounds
AU471999B2 (en) Substituted amino-acetylamino-benzophenone compounds
CA1013360A (en) Amino-indazole compounds
AU458655B2 (en) Benzenesulfonylurea derivatives
AU7072074A (en) Heterocyclic compounds
ZA741859B (en) Heterocyclic compounds
AU466024B2 (en) Thienodiazepine compounds
AU481939B2 (en) 7-acetoacetamidocephem compounds
AU486017B2 (en) Menthol-release compounds
AU482852B2 (en) Novel n-hydroxy-amidine compounds
AU480633B2 (en) Sulfilimine compounds
AU470521B2 (en) 5-benzyl-pyrimidine derivatives